These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 21035878)

  • 1. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies.
    Loane DJ; Faden AI
    Trends Pharmacol Sci; 2010 Dec; 31(12):596-604. PubMed ID: 21035878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective strategies for traumatic brain injury: improving clinical translation.
    Kabadi SV; Faden AI
    Int J Mol Sci; 2014 Jan; 15(1):1216-36. PubMed ID: 24445258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigational agents for treatment of traumatic brain injury.
    Xiong Y; Zhang Y; Mahmood A; Chopp M
    Expert Opin Investig Drugs; 2015 Jun; 24(6):743-60. PubMed ID: 25727893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection: challenges and opportunities.
    Faden AI; Stoica B
    Arch Neurol; 2007 Jun; 64(6):794-800. PubMed ID: 17562927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring new routes for neuroprotective drug development in traumatic brain injury.
    Janowitz T; Menon DK
    Sci Transl Med; 2010 Apr; 2(27):27rv1. PubMed ID: 20393189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection for traumatic brain injury.
    Loane DJ; Stoica BA; Faden AI
    Handb Clin Neurol; 2015; 127():343-66. PubMed ID: 25702227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-Injury Administration of Mitochondrial Uncouplers Increases Tissue Sparing and Improves Behavioral Outcome following Traumatic Brain Injury in Rodents.
    Pandya JD; Pauly JR; Nukala VN; Sebastian AH; Day KM; Korde AS; Maragos WF; Hall ED; Sullivan PG
    J Neurotrauma; 2007 May; 24(5):798-811. PubMed ID: 17518535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in neuroprotection for treating traumatic brain injury.
    Cernak I
    Expert Opin Investig Drugs; 2006 Nov; 15(11):1371-81. PubMed ID: 17040197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone neuroprotection: The background of clinical trial failure.
    Schumacher M; Denier C; Oudinet JP; Adams D; Guennoun R
    J Steroid Biochem Mol Biol; 2016 Jun; 160():53-66. PubMed ID: 26598278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins improve outcome in murine models of intracranial hemorrhage and traumatic brain injury: a translational approach.
    Indraswari F; Wang H; Lei B; James ML; Kernagis D; Warner DS; Dawson HN; Laskowitz DT
    J Neurotrauma; 2012 May; 29(7):1388-400. PubMed ID: 22233347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention.
    Kumar A; Loane DJ
    Brain Behav Immun; 2012 Nov; 26(8):1191-201. PubMed ID: 22728326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?
    Lerouet D; Marchand-Leroux C; Besson VC
    Fundam Clin Pharmacol; 2021 Jun; 35(3):524-538. PubMed ID: 33527472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?
    Marklund N; Hillered L
    Br J Pharmacol; 2011 Oct; 164(4):1207-29. PubMed ID: 21175576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging treatments for traumatic brain injury.
    Xiong Y; Mahmood A; Chopp M
    Expert Opin Emerg Drugs; 2009 Mar; 14(1):67-84. PubMed ID: 19249984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats.
    Thornton E; Vink R; Blumbergs PC; Van Den Heuvel C
    Brain Res; 2006 Jun; 1094(1):38-46. PubMed ID: 16697978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection Trials in Traumatic Brain Injury.
    Chakraborty S; Skolnick B; Narayan RK
    Curr Neurol Neurosci Rep; 2016 Apr; 16(4):29. PubMed ID: 26883431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigational neuroprotective drugs in traumatic brain injury.
    Cawley MJ; Marburger RK; Earl GL
    J Neurosci Nurs; 1998 Dec; 30(6):369-74. PubMed ID: 9949976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of traumatic brain injury.
    Xiong Y; Mahmood A; Chopp M
    Nat Rev Neurosci; 2013 Feb; 14(2):128-42. PubMed ID: 23329160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targets of Neuroprotection and Review of Pharmacological Interventions in Traumatic Brain Injury.
    Hiskens MI
    J Pharmacol Exp Ther; 2022 Aug; 382(2):149-166. PubMed ID: 35644464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of resveratrol against traumatic brain injury in immature rats.
    Sönmez U; Sönmez A; Erbil G; Tekmen I; Baykara B
    Neurosci Lett; 2007 Jun; 420(2):133-7. PubMed ID: 17531385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.